Top Markets
Coin of the day
Medesis Pharma S.A. Medesis Pharma S.A.

Medesis Pharma S.A.

ALMDP
Rangering i aksjer #37493
Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development... Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development phase, dedicated to creating orally delivered molecular drug therapies aimed at critical medical conditions lacking effective treatments. The company's pipeline features several innovative compounds, including NanoLithium (NP03), which is currently undergoing clinical trials for Alzheimer's disease, and NanosiRNA DH, targeting Huntington's Disease. Medesis Pharma also develops NU01 Plutonium and NU02 Cesium for nuclear decorporation, alongside NP02 – NanoManganese, a radioprotection medication designed for individuals exposed to radiation from nuclear incidents. Furthermore, their portfolio encompasses NanosiRNA COVID-19, an antiviral solution for various viral infections, and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for oncological applications. Established in 2003, the enterprise operates from its headquarters in Montpellier, France.
Aksjekurs
$0.38207938
Sist synkronisert: 2025-04-07
Markedsverdi
$1.67M
Endring (1 dag)
-0.39%
Endring (1 år)
0.00%
Land
FR
Handel Medesis Pharma S.A. (ALMDP)

Kategori

Aksjeprishistorikk for Medesis Pharma S.A. (ALMDP)
Høyeste sluttskurs: $0.38 den 2025-04-01

Laveste sluttskurs: $15.89 den 2021-02-01
Aksjeprishistorikk for Medesis Pharma S.A. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2025 7.86%
2024 -63.03%
2023 -54.06%
2022 -64.90%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE